Feb 22

New Biologics Guidelines for Low Back Pain

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']The use of regenerative medicine has been expanding as its power to help heal patients has become increasingly apparent. However, the decision about what and who to treat with these therapeutic compounds can be tricky, especially given the variable and occasionally scarce data about certain applications. TOBI Alumni Faculty, Annu Navani has spearheaded a massive effort in collaboration with the American Society of Interventional Pain Physicians (ASIPP) to bring clarity to the use of biologic therapies...

Mar 13

What’s New in Interventional Spine Biologics? Studies from TOBI Faculty

This year TOBI has added a workshop and cadaver lab track: Interventional Spine/Pain Management Biologics. Catch up with our Faculty publications in spine before joining us in June at TOBI 2017: 22 Feb 2018; Oxford University Press: Pain Medicine Increased Nuclear T2 Signal Intensity and Improved Function and Pain in a Patient One Year After an Intradiscal Platelet–Rich Plasma Injection Dr. Gregory Lutz of the Hospital for Special Surgery continues his remarkable research on intradiscal platelet-rich plasma (PRP) injections in this new publication...

Feb 9

January 2017: TOBI Faculty Publications in Regenerative Medicine

TOBI Faculty Publications: January 2017 January 2017, Stem Cells and Development Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro. TOBI Faculty C. Wayne McIlwraith, MD, published this study evaluating different methods of modulating inflammatory processes related to acute or chronic musculoskeletal injuries in the horse. They conducted studies to assess the immunological properties of equine allogeneic BMDMSCs compared with those of autologous BMDMSCs. For assessment of inherent immunogenicity, the relative ability of allogeneic and autologous...